Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Depreciation & Amortization (CF) (2023 - 2025)

Metagenomi (MGX) has disclosed Depreciation & Amortization (CF) for 3 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 11.76% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.3 million, a 1.85% decrease, with the full-year FY2025 number at $5.3 million, down 1.85% from a year prior.
  • Depreciation & Amortization (CF) was $1.3 million for Q4 2025 at Metagenomi, down from $1.3 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.5 million in Q4 2024 to a low of $841000.0 in Q1 2023.
  • A 3-year average of $1.2 million and a median of $1.3 million in 2024 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): skyrocketed 51.37% in 2024, then fell 11.76% in 2025.
  • Metagenomi's Depreciation & Amortization (CF) stood at $1.2 million in 2023, then increased by 21.78% to $1.5 million in 2024, then dropped by 11.76% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Depreciation & Amortization (CF) are $1.3 million (Q4 2025), $1.3 million (Q3 2025), and $1.3 million (Q2 2025).